FDA applicant

Vanguard Biomedical Corp.

San Diego, CA10 decisions1988–19960 recalls

FDA records 10 decisions for Vanguard Biomedical Corp. (San Diego, CA) from 1988 to 1996: 10 510(k) clearances. Most are in product codes LCX (Kit, Test, Pregnancy, Hcg, Over The Counter) and CEP (Radioimmunoassay, Luteinizing Hormone). Its devices cite 1 predicate, 1 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Vanguard Biomedical Corp.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Vanguard Biomedical Corp. since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Vanguard Biomedical Corp. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Vanguard Biomedical Corp.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Vanguard”

FDA records each applicant name separately; these may or may not be the same firm.

Vanguard Medical Concepts, Inc. 33 Vanguard Diagnostic Systems 2 Vanguard Container Corp. 1

Vanguard Biomedical Corp.

Which product codes does it file in?

Who builds on its devices?

Which of its devices are cited most?

What has FDA decided for it lately?

Other applicant names beginning “Vanguard”